Key stats
- Market cap
- 292B
- Open
- —
- Day range
- —
- 52-week range
- $153.41 – $212.71
- Volume
- 1.69M
- Avg volume
- 3.04M
Q2 FY16
Actual$0.00
AZN
AstraZeneca$188.03+$3.65+1.98%Price as of Nov 13, 2026, 7:59 PM ET
Earnings
Q1 FY16
Actual$0.51
Q4 FY15
Actual$0.64
Q3 FY15
Actual$0.60
About
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
- Employees
- 96,100